Coffee consumption and reduced risk of hepatocellular carcinoma: Findings from the Singapore Chinese Health Study

Cancer Causes and Control

Volumn 22, Issue 3, 2011, Pages 503-510

  Johnson, Shane ^a,b   Koh, Woon Puay ^b   Wang, Renwei ^a   Govindarajan, Sugantha ^c,d   Yu, Mimi C ^a   Yuan, Jian Min ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Caffeine; Coffee; GGT; HCC; Hepatocellular; Liver cancer

Indexed keywords

CAFFEINE;

ADULT; AGED; ARTICLE; CANCER RISK; CHINESE; COFFEE; COHORT ANALYSIS; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; HUMAN; INTERVIEW; LIFESTYLE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK REDUCTION; SEX DIFFERENCE; SINGAPORE; TEA;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; COFFEE; COHORT STUDIES; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED; RISK REDUCTION BEHAVIOR; SINGAPORE; TEA;

EID: 79955756300     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-010-9725-0     Document Type: Article

References (39)

1. Ferlay J et al (2004) GLOBOCAN 2002: Cancer incidence, mortality, and prevalence worldwide, in IARC cancerbase No. 5 version 2.0. International Agency for Research of Cancer, Lyon
2. Yu MC, Yuan JM (2004) Environmental factors and risk for hepatocellular carcinoma. Gastroenterology 127(5 Suppl 1):S72-S78 (Pubitemid 39423372)
3. Azam S et al (2003) Antioxidant and prooxidant properties of caffeine, theobromine and xanthine. Med Sci Monit 9(9):BR325- BR330 (Pubitemid 37295227)
4. Okano J et al (2008) Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway. Basic Clin Pharmacol Toxicol 102(6):543-551 (Pubitemid 351691962)
5. Hosaka S et al (2001) Hepatocarcinogenesis inhibition by caffeine in ACI rats treated with 2-acetylaminofluorene. Food Chem Toxicol 39(6):557-561 (Pubitemid 32429468)
6. Nakanishi N et al (2000) Effects of coffee consumption against the development of liver dysfunction: A 4-year follow-up study of middle-aged Japanesemale office workers. IndHealth 38(1):99-102 (Pubitemid 30091138)
7. Gross G, Jaccaud E, Huggett AC (1997) Analysis of the content of the diterpenes cafestol and kahweol in coffee brews. Food Chem Toxicol 35(6):547-554 (Pubitemid 27273775)
8. Cavin C et al (2001) Protective effects of coffee diterpenes against aflatoxin B1-induced genotoxicity: Mechanisms in rat and human cells. Food Chem Toxicol 39(6):549-556 (Pubitemid 32429467)
9. Eaton DL, Gallagher EP (1994) Mechanisms of aflatoxin carcinogenesis. Annu Rev Pharmacol Toxicol 34:135-172
10. Cavin C et al (2002) Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol 40(8):1155-1163 (Pubitemid 34626880)
11. Gallus S et al (2002) Does coffee protect against hepatocellular carcinoma? Br J Cancer 87(9):956-959 (Pubitemid 35305644)
12. Gelatti U et al (2005) Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: A casecontrol study. J Hepatol 42(4):528-534 (Pubitemid 40342932)
13. Inoue M et al (2005) Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: A prospective study in Japan. J Natl Cancer Inst 97(4):293-300 (Pubitemid 40310277)
14. Kurozawa Y et al (2005) Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan. Br J Cancer 93(5):607-610 (Pubitemid 43080007)
15. Montella M et al (2007) Coffee and tea consumption and risk of hepatocellular carcinoma in Italy. Int J Cancer 120(7):1555-1559 (Pubitemid 46355393)
16. Shimazu T et al (2005) Coffee consumption and the risk of primary liver cancer: Pooled analysis of two prospective studies in Japan. Int J Cancer 116(1):150-154 (Pubitemid 40827769)
17. Tanaka K et al (2007) Inverse association between coffee drinking and the risk of hepatocellular carcinoma: A case-control study in Japan. Cancer Sci 98(2):214-218 (Pubitemid 44941873)
18. Wakai K et al (2007) Liver cancer risk, coffee, and hepatitis C virus infection: A nested case-control study in Japan. Br J Cancer 97(3):426-428 (Pubitemid 47196758)
19. Larsson SC, Wolk A (2007) Coffee consumption and risk of liver cancer: A meta-analysis. Gastroenterology 132(5):1740-1745 (Pubitemid 46677953)
20. Bravi F et al (2007) Coffee drinking and hepatocellular carcinoma risk: A meta-analysis. Hepatology 46(2):430-435 (Pubitemid 47344778)
21. Parkin DM, Whelan S, Ferlay J, Storm H (2005) Cancer incidence in five continents Vol 1 to VIII. IARC CancerBase No. 7, Lyon
22. Hankin JH et al (2001) Singapore Chinese Health Study: Development, validation, and calibration of the quantitative food frequency questionnaire. Nutr Cancer 39(2):187-195 (Pubitemid 33694034)
23. Seow A et al (1998) Urinary total isothiocyanate (ITC) in a population-based sample of middle-aged and older Chinese in Singapore: Relationship with dietary total ITC and glutathione S-transferase M1/T1/P1 genotypes. Cancer Epidemiol Biomarkers Prev 7(9):775-781 (Pubitemid 28420615)
24. Parkin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 2(9):533-543 (Pubitemid 33586866)
25. Nieters A et al (2005) Effect of cytokine genotypes on the hepatitis B virus-hepatocellular carcinoma association. Cancer 103(4):740-748 (Pubitemid 40216402)
26. Breslow NE, Day NE (1980) Statistical methods in cancer research. Volume I-The analysis of case-control studies. IARC Sci Publ 32:5-338
27. Ruhl CE, Everhart JE (2005) Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology 129(6):1928-1936 (Pubitemid 41772970)
28. Klatsky AL, Armstrong MA (1992) Alcohol, smoking, coffee, and cirrhosis. Am J Epidemiol 136(10):1248-1257 (Pubitemid 23026896)
29. Cavin C et al (2008) Induction of Nrf2-mediated cellular defenses and alteration of phase I activities as mechanisms of chemoprotective effects of coffee in the liver. Food Chem Toxicol 46(4):1239-1248 (Pubitemid 351265379)
30. Cavin C et al (1998) The coffee-specific diterpenes cafestol and kahweol protect against aflatoxin B1-induced genotoxicity through a dual mechanism. Carcinogenesis 19(8):1369-1375 (Pubitemid 28409833)
31. Scholl P et al (1995) Molecular biomarkers for aflatoxins and their application to human liver cancer. Pharmacogenetics 5 Spec No:S171-S176
32. Peterson S et al (2010) Coffee intake and risk of colorectal cancer among Chinese in Singapore: The Singapore Chinese Health Study. Nutr Cancer 62(1):21-29
33. Feng R et al (2005) Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J Biol Chem 280(30):27888-27895 (Pubitemid 41076906)
34. Mukhtar M et al (2000) Anti-human immunodeficiency virus type 1 gene therapy in human central nervous system-based cells: An initial approach against a potential viral reservoir. Hum Gene Ther 11(2):347-359 (Pubitemid 30080391)
35. Erba D et al (2005) Effectiveness of moderate green tea consumption on antioxidative status and plasma lipid profile in humans. J Nutr Biochem 16(3):144-149 (Pubitemid 40312166)
36. Ui A et al (2009) Green tea consumption and the risk of liver cancer in Japan: The Ohsaki Cohort study. Cancer Causes Control 20(10):1939-1945
37. InoueMet al (2009) Effect of coffee and green tea consumption on the risk of liver cancer: Cohort analysis by hepatitis virus infection status. Cancer Epidemiol Biomarkers Prev 18(6):1746-1753
38. Kurozawa Y et al (2004) Dietary habits and risk of death due to hepatocellular carcinoma in a large scale cohort study in Japan. Univariate analysis of JACC study data. Kurume Med J 51(2): 141-149 (Pubitemid 39106858)
39. Nagano J et al (2001) A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan). Cancer Causes Control 12(6):501-508 (Pubitemid 32735122)